Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15203-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15203-1-AP, RRID:AB_2199582
- Product name
- TFCP2 antibody
- Antibody type
- Polyclonal
- Description
- TFCP2 antibody (Cat. #15203-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The genetic and epigenetic regulation of CD55 and its pathway analysis in colon cancer.
TFCP2, a binding protein of ATF3, promotes the progression of glioma by activating the synthesis of serine.
Early-life exposure to bisphenol A induces dysregulation of lipid homeostasis by the upregulation of SCD1 in male mice.
Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis.
TFCP2 Overcomes Senescence by Cooperating With SREBP2 to Activate Cholesterol Synthesis in Pancreatic Cancer.
DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
MicroRNA-144 is regulated by CP2 and decreases COX-2 expression and PGE2 production in mouse ovarian granulosa cells.
Liu J, Fu N, Yang Z, Li A, Wu H, Jin Y, Song Q, Ji S, Xu H, Zhang Z, Zhang X
Frontiers in immunology 2022;13:947136
Frontiers in immunology 2022;13:947136
TFCP2, a binding protein of ATF3, promotes the progression of glioma by activating the synthesis of serine.
Luo X, Ge J, Liu J, Liu Z, Bi C, Lan S
Experimental cell research 2022 Jul 1;416(1):113136
Experimental cell research 2022 Jul 1;416(1):113136
Early-life exposure to bisphenol A induces dysregulation of lipid homeostasis by the upregulation of SCD1 in male mice.
Fang R, Yang S, Gu X, Li C, Bi N, Wang HL
Environmental pollution (Barking, Essex : 1987) 2022 Jul 1;304:119201
Environmental pollution (Barking, Essex : 1987) 2022 Jul 1;304:119201
Overexpressed integrin alpha 2 inhibits the activation of the transforming growth factor β pathway in pancreatic cancer via the TFCP2-SMAD2 axis.
Cai H, Guo F, Wen S, Jin X, Wu H, Ren D
Journal of experimental & clinical cancer research : CR 2022 Feb 22;41(1):73
Journal of experimental & clinical cancer research : CR 2022 Feb 22;41(1):73
TFCP2 Overcomes Senescence by Cooperating With SREBP2 to Activate Cholesterol Synthesis in Pancreatic Cancer.
Zhang D, Lu P, Zhu K, Wu H, Dai Y
Frontiers in oncology 2021;11:724437
Frontiers in oncology 2021;11:724437
DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
Shao K, Pu W, Zhang J, Guo S, Qian F, Glurich I, Jin Q, Ma Y, Ju S, Zhang Z, Ding W
Clinical epigenetics 2021 Apr 23;13(1):89
Clinical epigenetics 2021 Apr 23;13(1):89
MicroRNA-144 is regulated by CP2 and decreases COX-2 expression and PGE2 production in mouse ovarian granulosa cells.
Zhou J, Lei B, Li H, Zhu L, Wang L, Tao H, Mei S, Li F
Cell death & disease 2017 Feb 9;8(2):e2597
Cell death & disease 2017 Feb 9;8(2):e2597
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TFCP2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TFCP2. This antibody recognizes human, mouse, rat antigen. The TFCP2 antibody has been validated for the following applications: ELISA, WB analysis.